Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Suji Jeong is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/02/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
06/07/2023 | PRTK | Buy Now | Paratek Pharmaceuticals | — | — | Suji Jeong26% | $5 → $2.15 | Downgrade | Buy → Hold | Get Alert |
04/19/2023 | BLU | Buy Now | BELLUS Health | — | — | Suji Jeong26% | $21 → $14.75 | Downgrade | Buy → Hold | Get Alert |
04/03/2023 | SVRA | Buy Now | Savara | $2.87 | -30.31% | Suji Jeong26% | → $2 | Downgrade | Buy → Hold | Get Alert |
03/23/2023 | INZY | Buy Now | Inozyme Pharma | $0.91 | 556.81% | Suji Jeong26% | $4.5 → $6 | Upgrade | Hold → Buy | Get Alert |
09/23/2022 | BLU | Buy Now | BELLUS Health | — | — | Suji Jeong26% | $14 → $21 | Maintains | Buy | Get Alert |
09/16/2022 | ANNX | Buy Now | Annexon | $1.86 | 545.16% | Suji Jeong26% | → $12 | Initiates | → Buy | Get Alert |
05/26/2022 | INZY | Buy Now | Inozyme Pharma | $0.91 | 447.35% | Suji Jeong26% | → $5 | Initiates | → Hold | Get Alert |
01/31/2022 | STOK | Buy Now | Stoke Therapeutics | $6.29 | 694.91% | Suji Jeong26% | → $50 | Initiates | → Buy | Get Alert |
03/02/2021 | PRTK | Buy Now | Paratek Pharmaceuticals | — | — | Suji Jeong26% | → $15 | Initiates | → Buy | Get Alert |